3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole has been researched along with pulmicort in 2 studies
| Studies (3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole) | Trials (3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole) | Recent Studies (post-2010) (3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole) | Studies (pulmicort) | Trials (pulmicort) | Recent Studies (post-2010) (pulmicort) |
|---|---|---|---|---|---|
| 10 | 3 | 3 | 4,995 | 1,638 | 1,785 |
| Protein | Taxonomy | 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole (IC50) | pulmicort (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.0026 | |
| Progesterone receptor | Homo sapiens (human) | 0.028 | |
| Glucocorticoid receptor | Rattus norvegicus (Norway rat) | 0.0029 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.0045 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 0.014 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 1.989 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 1.1725 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.0045 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.0045 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.0045 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulet, LP; Bousquet, J; Carlsheimer, A; Magnussen, H; Martinez-Aguilar, NE; Peters, MJ; Quiralte, J | 1 |
| Kardos, P | 1 |
2 trial(s) available for 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole and pulmicort
| Article | Year |
|---|---|
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Azides; Budesonide; Child; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Hospitalization; Humans; Lung; Male; Middle Aged; Proportional Hazards Models; Respiratory Function Tests; Serotonin; Treatment Outcome | 2007 |
Budesonide/formoterol maintenance and reliever therapy versus free-combination therapy for asthma: a real-life study.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Azides; Budesonide; Drug Therapy, Combination; Ethanolamines; Female; Formoterol Fumarate; Germany; Humans; Male; Middle Aged; Prevalence; Quality of Life; Risk Factors; Self Administration; Serotonin; Treatment Outcome | 2013 |